SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-055250
Filing Date
2022-05-03
Accepted
2022-05-03 16:01:39
Documents
1
Period of Report
2022-05-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2214270-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2214270-1_4seq1.xml 4 3404
  Complete submission text file 0001104659-22-055250.txt   4841
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address
Freedberg Jared (Reporting) CIK: 0001754157 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 22886707